A study validating changes in the Multiple Sclerosis Functional Composite

被引:32
作者
Hoogervorst, ELJ
Kalkers, NF
Uitdehaag, BMJ
Polman, CH
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands
关键词
D O I
10.1001/archneur.59.1.113
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To prospectively characterize the relation between 1-year changes in neurologist ratings of abnormalities as measured by means of the Expanded Disability Status Scale (EDSS) and changes in observations of functional impairment as measured by means of the Multiple Sclerosis Functional Composite (MSFC) in the clinical assessment of multiple sclerosis (MS). Methods: One hundred twenty patients with MS were recruited at our outpatient clinic. Impairment and disability at baseline and follow-up were assessed using the EDSS and MSFC. We studied correlations between change (A) in the EDSS, MSFC, and MSFC components for the total population and different subgroups and analyzed the contribution of change in MSFC components to change in the EDSS and MSFC. Results: Median EDSS score at baseline was 4.5; at follow-up, 5.0. Mean MSFC score at baseline was -0.00; at follow-up, -0.04. Good cross-sectional correlations were found between the EDSS and MSFC at baseline (-0.72) and follow-up (-0.73). Only weak correlations were found between DeltaEDSS and DeltaMSFC. Although DeltaEDSS showed the strongest correlations with change in leg function and weak or no correlation with change in cognitive function or arm function, DeltaMSFC showed the highest correlation with change in arm function and cognitive function. Conclusion: Our longitudinal data indicate that the MSFC reflects change from different dimensions of neurologic functions, which is a favorable characteristic when compared with the EDSS.
引用
收藏
页码:113 / 116
页数:4
相关论文
共 16 条
[1]  
[Anonymous], 1999, Administration and scoring manual for the multiple sclerosis functional composite measure (MSFC)
[2]   Intrarater and interrater reliability of the MS functional composite outcome measure [J].
Cohen, JA ;
Fischer, JS ;
Bolibrush, DM ;
Jak, AJ ;
Kniker, JE ;
Mertz, LA ;
Skaramagas, TT ;
Cutter, GR .
NEUROLOGY, 2000, 54 (04) :802-806
[3]   Development of a multiple sclerosis functional composite as a clinical trial outcome measure [J].
Cutter, GR ;
Baier, ML ;
Rudick, RA ;
Cookfair, DL ;
Fischer, JS ;
Petkau, J ;
Syndulko, K ;
Weinshenker, BG ;
Antel, JP ;
Confavreux, C ;
Ellison, GW ;
Lublin, F ;
Miller, AE ;
Rao, SM ;
Reingold, S ;
Thompson, A ;
Willoughby, E .
BRAIN, 1999, 122 :871-882
[4]   Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients [J].
Fisher, E ;
Rudick, RA ;
Cutter, G ;
Baier, M ;
Miller, D ;
Weinstock-Guttman, B ;
Mass, MK ;
Dougherty, DS ;
Simonian, NA .
MULTIPLE SCLEROSIS, 2000, 6 (06) :373-377
[5]   EDSS RELIABILITY [J].
GOODKIN, DE .
NEUROLOGY, 1991, 41 (02) :332-332
[6]   Kurtzke scales revisited: the application of psychometric methods to clinical intuition [J].
Hobart, J ;
Freeman, J ;
Thompson, A .
BRAIN, 2000, 123 :1027-1040
[7]   Comparisons of patient self-report, neurologic examination, and functional impairment in MS [J].
Hoogervorst, ELJ ;
van Winsen, LML ;
Eikelenboom, MJ ;
Kalkers, NF ;
Uitdehaag, BMJ ;
Polman, CH .
NEUROLOGY, 2001, 56 (07) :934-937
[8]   MS Functional Composite -: Relation to disease phenotype and disability strata [J].
Kalkers, NF ;
de Groot, V ;
Lazeron, RHC ;
Killestein, J ;
Adèr, HJ ;
Barkhof, F ;
Lankhorst, GJ ;
Polman, CH .
NEUROLOGY, 2000, 54 (06) :1233-1239
[9]  
KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444
[10]   Defining the clinical course of multiple sclerosis: Results of an international survey [J].
Lublin, FD ;
Reingold, SC .
NEUROLOGY, 1996, 46 (04) :907-911